Prescient Therapeutics Limited (ASX:PTX)
Australia
· Delayed Price · Currency is AUD 0.0550
-0.0050 (-8.33%)
At close: Mar 9, 2026
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 57.83 million as of March 9, 2026. Its market cap has increased by 46.56% in one year.
Market Cap
57.83M
Enterprise Value
48.34M
Revenue
4.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 57.83M, an increase of 910.27%. That is a compound annual growth rate of 8.60%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 57.29M |
| Amplia Therapeutics | 56.44M |
| Proteomics International Laboratories | 53.68M |
| Radiopharm Theranostics | 74.43M |
| Entropy Neurodynamics | 53.31M |
| Imugene | 75.56M |
| Alterity Therapeutics | 76.13M |
| EZZ Life Science Holdings | 51.07M |